From the, Laboratory of Behavioral Neurobiology, The Rockefeller University, New York, New York.
Alcohol Clin Exp Res. 2020 Dec;44(12):2519-2535. doi: 10.1111/acer.14482. Epub 2020 Nov 16.
Embryonic exposure to ethanol (EtOH) produces marked disturbances in neuronal development and alcohol-related behaviors, with low-moderate EtOH doses stimulating neurogenesis without producing apoptosis and high doses having major cytotoxic effects while causing gross morphological abnormalities. With the pro-inflammatory chemokine system, Cxcl12, and its main receptor Cxcr4, known to promote processes of neurogenesis, we examined here this neuroimmune system in the embryonic hypothalamus to test directly if it mediates the stimulatory effects low-moderate EtOH doses have on neuronal development.
We used the zebrafish (Danio rerio) model, which develops externally and allows one to investigate the developing brain in vivo with precise control of dose and timing of EtOH delivery in the absence of maternal influence. Zebrafish were exposed to low-moderate EtOH doses (0.1, 0.25, 0.5% v/v), specifically during a period of peak hypothalamic development from 22 to 24 hours postfertilization, and in some tests were pretreated from 2 to 22 hpf with the Cxcr4 receptor antagonist, AMD3100. Measurements in the hypothalamus at 26 hpf were taken of cxcl12a and cxcr4b transcription, signaling, and neuronal density using qRT-PCR, RNAscope, and live imaging of transgenic zebrafish.
Embryonic EtOH exposure, particularly at the 0.5% dose, significantly increased levels of cxcl12a and cxcr4b mRNA in whole embryos, number of cxcl12a and cxcr4b transcripts in developing hypothalamus, and internalization of Cxcr4b receptors in hypothalamic cells. Embryonic EtOH also caused an increase in the number of hypothalamic neurons and coexpression of cxcl12a and cxcr4b transcripts within these neurons. Each of these stimulatory effects of EtOH in the embryo was blocked by pretreatment with the Cxcr4 antagonist AMD3100.
These results provide clear evidence that EtOH's stimulatory effects at low-moderate doses on the number of hypothalamic neurons early in development are mediated, in part, by increased transcription and intracellular activation of this chemokine system, likely due to autocrine signaling of Cxcl12a at its Cxcr4b receptor within the neurons.
胚胎暴露于乙醇(EtOH)会导致神经元发育和与酒精相关的行为出现明显紊乱,低-中等剂量的 EtOH 刺激神经发生而不产生细胞凋亡,高剂量则具有主要的细胞毒性作用,同时导致明显的形态异常。已知趋化因子系统 Cxcl12 及其主要受体 Cxcr4 促进神经发生过程,我们在这里研究胚胎下丘脑的这种神经免疫系统,以直接测试其是否介导低-中等剂量 EtOH 对神经元发育的刺激作用。
我们使用斑马鱼(Danio rerio)模型,该模型在体外发育,允许我们在没有母体影响的情况下,精确控制 EtOH 剂量和给予时间,从而研究发育中的大脑。斑马鱼在受精后 22 至 24 小时的下丘脑发育高峰期接受低-中等剂量 EtOH(0.1%、0.25%、0.5%v/v)暴露,在某些测试中,从 2 至 22 小时受精前用 Cxcr4 受体拮抗剂 AMD3100 预处理。在 26 小时受精时,通过 qRT-PCR、RNAscope 和转基因斑马鱼的活体成像,测量下丘脑 cxcl12a 和 cxcr4b 的转录、信号转导和神经元密度。
胚胎 EtOH 暴露,特别是在 0.5%的剂量下,显著增加了整个胚胎中 cxcl12a 和 cxcr4b mRNA 的水平、发育中的下丘脑 cxcl12a 和 cxcr4b 转录本的数量,以及下丘脑细胞中 Cxcr4b 受体的内化。胚胎 EtOH 还导致下丘脑神经元数量增加,并且 cxcl12a 和 cxcr4b 转录本在这些神经元中共同表达。这些 EtOH 在胚胎中的刺激作用都被 Cxcr4 拮抗剂 AMD3100 的预处理所阻断。
这些结果提供了明确的证据,证明 EtOH 在低-中等剂量下对早期发育中下丘脑神经元数量的刺激作用部分是由该趋化因子系统的转录和细胞内激活增加介导的,这可能是由于神经元内 Cxcl12a 对其 Cxcr4b 受体的自分泌信号。